GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy

Alzheimer’s is a prevalent, progressive neurodegenerative disease marked by cognitive decline and memory loss. The disease’s development involves various pathomechanisms, including amyloid-beta accumulation, neurofibrillary tangles, oxidative stress, inflammation, and mitochondrial dysfunction. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Złotek, Magdalena, Kurowska, Antonina, Herbet, Mariola, Piątkowska-Chmiel, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669527/
https://www.ncbi.nlm.nih.gov/pubmed/38002034
http://dx.doi.org/10.3390/biomedicines11113035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669527/
https://www.ncbi.nlm.nih.gov/pubmed/38002034
http://dx.doi.org/10.3390/biomedicines11113035

Ejemplares similares